I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| macrophage | 25 studies | 29% ± 14% | |
| non-classical monocyte | 21 studies | 37% ± 12% | |
| classical monocyte | 19 studies | 24% ± 8% | |
| B cell | 17 studies | 23% ± 6% | |
| monocyte | 16 studies | 29% ± 9% | |
| plasmacytoid dendritic cell | 12 studies | 30% ± 9% | |
| myeloid cell | 12 studies | 28% ± 12% | |
| microglial cell | 11 studies | 39% ± 16% | |
| memory B cell | 9 studies | 19% ± 3% | |
| naive B cell | 8 studies | 21% ± 3% | |
| natural killer cell | 7 studies | 18% ± 3% | |
| CD16-positive, CD56-dim natural killer cell, human | 6 studies | 17% ± 1% | |
| neutrophil | 5 studies | 19% ± 2% | |
| precursor B cell | 5 studies | 35% ± 12% | |
| dendritic cell | 5 studies | 21% ± 8% | |
| pro-B cell | 4 studies | 32% ± 5% | |
| mononuclear phagocyte | 4 studies | 27% ± 8% | |
| alveolar macrophage | 4 studies | 28% ± 11% | |
| conventional dendritic cell | 3 studies | 28% ± 10% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 19% ± 1% | |
| immature B cell | 3 studies | 20% ± 3% | |
| tissue-resident macrophage | 3 studies | 24% ± 10% | |
| germinal center B cell | 3 studies | 25% ± 4% | |
| hepatocyte | 3 studies | 39% ± 27% | |
| abnormal cell | 3 studies | 17% ± 1% |
